News Choose Language View All Languages English Press Releases Spanish Press Releases Sort by Year All Years 2023 (11) 2022 (29) 2021 (17) 2020 (19) 2019 (12) 2018 (18) 2017 (19) 2016 (32) 2015 (43) 2014 (50) 2013 (32) 2012 (17) Search May 23, 2023 Theriva Biologics Announces Appointment of Ramon Alemany, Ph.D., to Senior Vice President of Discovery May 11, 2023 Theriva Biologics Reports First Quarter 2023 Operational Highlights and Financial Results May 4, 2023 Theriva Biologics to Host Conference Call and Webcast to Discuss First Quarter 2023 Operational Highlights and Financial Results April 13, 2023 Theriva Biologics Announces Presentation of Data from Cohort 1 of the Phase 1b/2a Clinical Trial of SYN-004 (ribaxamase) in Allogeneic Hematopoietic Cell Transplant Recipients March 30, 2023 Theriva Biologics Reports Fourth Quarter and Full-Year 2022 Operational Highlights and Financial Results March 24, 2023 Theriva Biologics to Reschedule Conference Call and Webcast to Discuss Fourth Quarter and Full-Year 2022 Operational Highlights and Financial Results March 20, 2023 Theriva Biologics to Host Conference Call and Webcast to Discuss Fourth Quarter and Full-Year 2022 Operational Highlights and Financial Results February 16, 2023 Theriva Biologics Announces Presentation of Safety and Pharmacokinetic Data from Cohort 1 of the Phase 1b/2a Clinical Trial of SYN-004 (ribaxamase) in Allogeneic Hematopoietic Cell Transplant Recipients January 17, 2023 Theriva Biologics Announces First Patient Dosed in VIRAGE, a Phase 2b Trial of Systemically Administered VCN-01 in Combination with Chemotherapy in Pancreatic Ductal Adenocarcinoma January 17, 2023 Theriva Biologics to Participate in the B. Riley Securities 3rd Annual Oncology Conference
